Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - A systematic review of in vitro data

被引:298
作者
Doktorovova, Slavomira [1 ,2 ]
Souto, Eliana B. [2 ,3 ]
Silva, Amelia M. [1 ,4 ]
机构
[1] Univ Tras Os Montes & Alto Douro, Sch Life & Environm Sci, ECVA, UTAD,Dept Biol & Environm, P-5001801 Vila Real, Portugal
[2] Univ Tras Os Montes & Alto Douro, Inst Biotechnol & Bioengn, Ctr Genom & Biotechnol, IBB CGB UTAD, Vila Real, Portugal
[3] Fernando Pessoa Univ, Dept Pharmaceut Technol, UFP, Porto, Portugal
[4] Univ Tras Os Montes & Alto Douro, Ctr Res & Technol Agroenvironm & Biol Sci, CITAB UTAD, Vila Real, Portugal
关键词
Lipid nanoparticles; Solid lipid nanoparticles; Nanostructured lipid carriers; Cytotoxicity; Genotoxicity; Oxidative stress; Blood compatibility; In vitro studies; OF-THE-ART; CELLULAR UPTAKE; DRUG-DELIVERY; PHYSICOCHEMICAL CHARACTERISTICS; MULTIDRUG-RESISTANCE; ANTIOXIDANT ACTIVITY; ANTICANCER ACTIVITY; CYTOKINE PRODUCTION; REVERSAL ACTIVITY; PHAGOCYTIC UPTAKE;
D O I
10.1016/j.ejpb.2014.02.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) were developed as alternative to other colloidal carriers. They were designed to overcome lipid nanoemulsions and liposomes in stability and ability to control the release of an encapsulated substance, and at the same time to be better tolerated than polymeric nanoparticles. Since the patenting of SLN discovery, large amount of data became available on the behaviour of these systems in vitro. SLN/NLC have many prerequisites to be a well tolerated carrier - the currently available data seem to confirm it, but there are also some contradictory results. In this review, we collected the available data from cytotoxicity, oxidative stress and hemocompatibility studies in vitro and analysed their outcomes. We also provide a summary of the available data in a form of reference table. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 133 条
[31]   The Imperative to Authenticate Cell Lines [J].
Healey, John H. .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2010, 468 (12) :3413-3414
[32]   Preparation and purification of cationic solid lipid nanospheres - effects on particle size, physical stability and cell toxicity [J].
Heydenreich, AV ;
Westmeier, R ;
Pedersen, N ;
Poulsen, HS ;
Kristensen, HG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 254 (01) :83-87
[33]   Characterization and Cytotoxicity of Nanostructured Lipid Carriers Formulated With Olive Oil, Hydrogenated Palm Oil, and Polysorbate 80 [J].
How, Chee W. ;
Rasedee, Abdullah ;
Abbasalipourkabir, Roghayeh .
IEEE TRANSACTIONS ON NANOBIOSCIENCE, 2013, 12 (02) :72-78
[34]   Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery [J].
Hu, LianDong ;
Jia, Yanhong ;
WenDing .
PHARMAZIE, 2010, 65 (08) :585-587
[35]   Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug [J].
Jain, Ashay ;
Agarwal, Abhinav ;
Majumder, Saikat ;
Lariya, Narendra ;
Khaya, Anil ;
Agrawal, Himanshu ;
Majumdar, Subrata ;
Agrawal, Govind P. .
JOURNAL OF CONTROLLED RELEASE, 2010, 148 (03) :359-367
[36]   Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy [J].
Jores, K ;
Mehnert, W ;
Drechsler, M ;
Bunjes, H ;
Johann, C ;
Mäder, K .
JOURNAL OF CONTROLLED RELEASE, 2004, 95 (02) :217-227
[37]   Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain [J].
Kakkar, Vandita ;
Kaur, Indu Pal .
FOOD AND CHEMICAL TOXICOLOGY, 2011, 49 (11) :2906-2913
[38]   Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin [J].
Khajavinia, Amir ;
Varshosaz, Jaleh ;
Dehkordi, Abbas Jafarian .
NANOTECHNOLOGY, 2012, 23 (40)
[39]   Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA [J].
Kim, Hyun Ryoung ;
Kim, In Kyoung ;
Bae, Ki Hyun ;
Lee, Soo Hyeon ;
Lee, Yuhan ;
Park, Tae Gwan .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :622-631
[40]   Cationic solid lipid nanoparticles derived from apolipoprotein-free LDLs for target specific systemic treatment of liver fibrosis [J].
Kong, Won Ho ;
Park, Kitae ;
Lee, Min-Young ;
Lee, Hwiwon ;
Sung, Dong Kyung ;
Hahn, Sei Kwang .
BIOMATERIALS, 2013, 34 (02) :542-551